The Study of Efficacy and Safety of Generic Methylphenidate Prolong-released Comparison With Original
Status:
Not yet recruiting
Trial end date:
2022-08-31
Target enrollment:
Participant gender:
Summary
This study is a cross-over trial, design to determine the efficacy and safety of generic and
original prolong-release methylphenidate (PR-MPH) in children with ADHD who had received
immediate-release methylphenidate treatment